Samarth Kulkarni Sells 19,582 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) Stock
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) CEO Samarth Kulkarni sold 19,582 shares of the stock in a transaction on Monday, April 15th. The stock was sold at an average price of $59.91, for a total value of $1,173,157.62. Following the completion of the sale, the chief executive officer now directly owns 208,122 shares […]
More Stories
WisdomTree U.S. High Yield Corporate Bond Fund Declares Dividend of $0.24 (NYSEARCA:QHY)
WisdomTree U.S. High Yield Corporate Bond Fund (NYSEARCA:QHY – Get Free Report) announced a dividend on Friday, November 22nd,NASDAQ Dividends...
FT Vest SMID Rising Dividend Ac (NYSEARCA:SDVD) Announces Dividend of $0.14
FT Vest SMID Rising Dividend Ac (NYSEARCA:SDVD – Get Free Report) announced a dividend on Friday, November 22nd,NASDAQ Dividends reports....
Airports of Thailand Public Company Limited (OTCMKTS:AIPUY) Plans Dividend Increase – $0.16 Per Share
Airports of Thailand Public Company Limited (OTCMKTS:AIPUY – Get Free Report) announced a dividend on Saturday, November 23rd,NASDAQ Dividends reports....
Corning Natural Gas (OTCMKTS:CNIG) vs. Centuri (NYSE:CTRI) Financial Comparison
Centuri (NYSE:CTRI – Get Free Report) and Corning Natural Gas (OTCMKTS:CNIG – Get Free Report) are both utilities companies, but...
Critical Analysis: Lucas GC (NASDAQ:LGCL) versus Sangoma Technologies (NASDAQ:SANG)
Institutional & Insider Ownership 39.7% of Sangoma Technologies shares are owned by institutional investors. 14.0% of Sangoma Technologies shares are...
Americans Need $5.3 Million Net Worth to Be Considered Financially Successful: Survey
By Naveen Athrappully Americans have high expectations of what it means to be financially successful but many of them do...